{"cve":"CVE-2015-3956","nvd":{"published":"2019-03-25T18:29:00.323","modified":"2026-06-17T00:26:32.327","status":"Modified","description":"Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior accept drug libraries, firmware updates, pump commands, and unauthorized configuration changes from unauthenticated devices on the host network. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.","cvss_v4":null,"cvss_v3":{"version":"3.0","vector":"CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H","score":9.8},"cwes":["CWE-345"],"references":["https://ics-cert.us-cert.gov/advisories/ICSA-15-161-01","https://ics-cert.us-cert.gov/advisories/ICSA-15-161-01"],"products":["pifzer:plum_a\\+3_infusion_system_firmware","pifzer:plum_a\\+_infusion_system_firmware","pifzer:symbiq_infusion_system_firmware"],"source":"nvd","synced_at":"2026-10-19T20:55:22.313337056+00:00"},"epss":{"cve":"CVE-2015-3956","score":0.00954,"percentile":0.61388,"date":"2026-10-31"},"kev":null,"osv":[],"attribution":["This product uses the NVD API but is not endorsed or certified by the NVD.","EPSS scores: FIRST Exploit Prediction Scoring System, https://www.first.org/epss","Known exploited vulnerabilities: CISA Known Exploited Vulnerabilities Catalog, https://www.cisa.gov/known-exploited-vulnerabilities-catalog","Package advisories: OSV (https://osv.dev), from the GitHub Advisory Database, PyPA, Go, RustSec and other ecosystem databases, under CC-BY 4.0 or CC0","CVE records: the CVE Program's CVE List (https://www.cve.org), under its terms of use (https://www.cve.org/Legal/TermsOfUse). CVE is a registered trademark of The MITRE Corporation; this product is not affiliated with the CVE Program."]}